drugset / Trial / NCT00034788

A Study on the Efficacy and Safety of Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers With REGRANEX

NCT00034788

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of REGRANEX® Gel compared with placebo when applied for up to 52 consecutive weeks to recurring or non-healing ulcers of the ankle or foot related to diabetes.

Timeline

Start
2000-12
Primary completion
Completion
2004-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Becaplermin Protein / enzyme biologic Topical